Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Variable radiologic lung nodule evaluation leads to divergent management recommendations.

Nair A, Bartlett EC, Walsh SLF, Wells AU, Navani N, Hardavella G, Bhalla S, Calandriello L, Devaraj A, Goo JM, Klein JS, MacMahon H, Schaefer-Prokop C, Seo JB, Sverzellati N, Desai SR; Lung Nodule Evaluation Group (Collaborators).

Eur Respir J. 2018 Nov 8. pii: 1801359. doi: 10.1183/13993003.01359-2018. [Epub ahead of print]

PMID:
30409817
2.

The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer: An Analysis Based on Individual Participant Data.

Navani N, Fisher D, Tierney JF, Stephens RJ, Burdett S; NSCLC Meta-analysis Collaborative Group.

Chest. 2018 Oct 26. pii: S0012-3692(18)32607-2. doi: 10.1016/j.chest.2018.10.020. [Epub ahead of print]

3.

Association between age, deprivation and specific comorbid conditions and the receipt of major surgery in patients with non-small cell lung cancer in England: A population-based study.

Belot A, Fowler H, Njagi EN, Luque-Fernandez MA, Maringe C, Magadi W, Exarchakou A, Quaresma M, Turculet A, Peake MD, Navani N, Rachet B.

Thorax. 2018 Aug 12. pii: thoraxjnl-2017-211395. doi: 10.1136/thoraxjnl-2017-211395. [Epub ahead of print]

4.

The continuum of screening and early detection, awareness and faster diagnosis of lung cancer.

Peake MD, Navani N, Baldwin DR.

Thorax. 2018 Dec;73(12):1097-1098. doi: 10.1136/thoraxjnl-2018-212189. Epub 2018 Aug 10. No abstract available.

PMID:
30097536
5.

Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: a qualitative study.

Evans R, Taylor S, Janes S, Halligan S, Morton A, Navani N, Oliver A, Rockall A, Teague J, Miles A; Streamline trials investigators.

BMJ Open. 2017 Sep 6;7(9):e016391. doi: 10.1136/bmjopen-2017-016391.

6.

Young at Heart: Is That Good Enough for Computed Tomography Screening?

Ruparel M, Navani N.

Am J Respir Crit Care Med. 2017 Sep 1;196(5):539-541. doi: 10.1164/rccm.201707-1504ED. No abstract available.

PMID:
28806529
7.

Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L).

Taylor SA, Mallett S, Miles A, Beare S, Bhatnagar G, Bridgewater J, Glynne-Jones R, Goh V, Groves AM, Janes SM, Koh DM, Morris S, Morton A, Navani N, Oliver A, Padhani AR, Punwani S, Rockall AG, Halligan S.

BMC Cancer. 2017 May 2;17(1):299. doi: 10.1186/s12885-017-3281-x.

8.

Incidental non-functional ectopic thyroid in a returning traveller.

Millar FR, Lambourne J, Thakrar R, Navani N.

Br J Hosp Med (Lond). 2016 Dec 2;77(12):720-721. No abstract available.

PMID:
27937021
9.

How should performance in EBUS mediastinal staging in lung cancer be measured?

Evison M, Crosbie P, Navani N, Callister M, Rintoul RC, Baldwin D, Booton R.

Br J Cancer. 2016 Oct 11;115(8):e9. doi: 10.1038/bjc.2016.253. Epub 2016 Aug 23. No abstract available.

10.

PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementation.

Cree IA, Booton R, Cane P, Gosney J, Ibrahim M, Kerr K, Lal R, Lewanski C, Navani N, Nicholson AG, Nicolson M, Summers Y.

Histopathology. 2016 Aug;69(2):177-86. doi: 10.1111/his.12996. Epub 2016 Jun 30. Review. Erratum in: Histopathology. 2017 Jan;70(2):318.

11.

Positive (18)Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Predicts Preinvasive Endobronchial Lesion Progression to Invasive Cancer.

Fraioli F, Kayani I, Smith LJ, Bomanji JB, Capitanio A, Falzon M, Carroll B, Navani N, Brown J, Thakrar RM, George PJ, Groves AM, Janes SM.

Am J Respir Crit Care Med. 2016 Mar 1;193(5):576-9. doi: 10.1164/rccm.201508-1617LE. No abstract available.

12.

Pulmonary nodules and CT screening: the past, present and future.

Ruparel M, Quaife SL, Navani N, Wardle J, Janes SM, Baldwin DR.

Thorax. 2016 Apr;71(4):367-75. doi: 10.1136/thoraxjnl-2015-208107. Epub 2016 Feb 26. Review.

13.

Isolation of a non-genomic origin fluoroquinolone responsive regulatory element using a combinatorial bioengineering approach.

Srivastava SK, Iyer VR, Ghosh T, Lambadi PR, Pathania R, Navani NK.

Nucleic Acids Res. 2016 Mar 18;44(5):2451-61. doi: 10.1093/nar/gkw029. Epub 2016 Feb 2.

14.

Secretory expression, characterization and docking study of glucose-tolerant β-glucosidase from B. subtilis.

Chamoli S, Kumar P, Navani NK, Verma AK.

Int J Biol Macromol. 2016 Apr;85:425-33. doi: 10.1016/j.ijbiomac.2016.01.001. Epub 2016 Jan 6.

PMID:
26772920
15.

Reply: Lung Cancer Susceptibility, Ethnicity, and the Benefits of Computed Tomography Screening.

Ruparel M, Navani N.

Am J Respir Crit Care Med. 2015 Dec 1;192(11):1396. doi: 10.1164/rccm.201508-1598LE. No abstract available.

PMID:
26623690
16.

Retracted: Bacteria diversity overview and endoglucanase assessment from Himalayan Tapovan geothermal spring.

Sahoo JK, Navani NK, Pathania R.

J Basic Microbiol. 2018 Jul;58(7):643. doi: 10.1002/jobm.201500135. Epub 2015 Aug 25.

PMID:
26617413
17.

A study on metabolic prowess of Pseudomonas sp. RPT 52 to degrade imidacloprid, endosulfan and coragen.

Gupta M, Mathur S, Sharma TK, Rana M, Gairola A, Navani NK, Pathania R.

J Hazard Mater. 2016 Jan 15;301:250-8. doi: 10.1016/j.jhazmat.2015.08.055. Epub 2015 Sep 29.

PMID:
26368799
18.

Transcriptional Profiling of Endobronchial Ultrasound-Guided Lymph Node Samples Aids Diagnosis of Mediastinal Lymphadenopathy.

Tomlinson GS, Thomas N, Chain BM, Best K, Simpson N, Hardavella G, Brown J, Bhowmik A, Navani N, Janes SM, Miller RF, Noursadeghi M.

Chest. 2016 Feb;149(2):535-544. doi: 10.1378/chest.15-0647. Epub 2016 Jan 12.

19.

Antibacterial potential of a small peptide from Bacillus sp. RPT-0001 and its capping for green synthesis of silver nanoparticles.

Patil SD, Sharma R, Bhattacharyya T, Kumar P, Gupta M, Chaddha BS, Navani NK, Pathania R.

J Microbiol. 2015 Sep;53(9):643-52. doi: 10.1007/s12275-015-4686-3. Epub 2015 Aug 1.

PMID:
26231370
20.

Fulfilling the Dream. Toward Reducing Inequalities in Lung Cancer Screening.

Ruparel M, Navani N.

Am J Respir Crit Care Med. 2015 Jul 15;192(2):125-7. doi: 10.1164/rccm.201505-0897ED. No abstract available.

PMID:
26177167
21.

Non-enzymatic detection of urea using unmodified gold nanoparticles based aptasensor.

Kumar P, Lambadi PR, Navani NK.

Biosens Bioelectron. 2015 Oct 15;72:340-7. doi: 10.1016/j.bios.2015.05.029. Epub 2015 May 12.

PMID:
26002019
22.

Facile biofunctionalization of silver nanoparticles for enhanced antibacterial properties, endotoxin removal, and biofilm control.

Lambadi PR, Sharma TK, Kumar P, Vasnani P, Thalluri SM, Bisht N, Pathania R, Navani NK.

Int J Nanomedicine. 2015 Mar 18;10:2155-71. doi: 10.2147/IJN.S72923. eCollection 2015.

23.

Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial.

Navani N, Nankivell M, Lawrence DR, Lock S, Makker H, Baldwin DR, Stephens RJ, Parmar MK, Spiro SG, Morris S, Janes SM; Lung-BOOST trial investigators.

Lancet Respir Med. 2015 Apr;3(4):282-9. doi: 10.1016/S2213-2600(15)00029-6. Epub 2015 Feb 4.

24.

Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non-Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized Trials.

Vale CL, Burdett S, Fisher DJ, Navani N, Parmar MK, Copas AJ, Tierney JF.

Clin Lung Cancer. 2015 May;16(3):173-182.e4. doi: 10.1016/j.cllc.2014.11.007. Epub 2014 Nov 22. Review.

25.

Massive pulmonary carcinoid tumor deemed inoperable until (68)Ga DOTATATE positron emission tomography/magnetic resonance imaging.

Ordidge KL, Brown JM, Succony L, Navani N, Hardavella G, Lawrence DR, Fraioli F, Groves A, Janes SM.

Am J Respir Crit Care Med. 2014 Sep 1;190(5):e16-7. doi: 10.1164/rccm.201309-1635IM. No abstract available.

PMID:
25171317
26.

Genetic regulation of spy gene expression in Escherichia coli in the presence of protein unfolding agent ethanol.

Srivastava SK, Lambadi PR, Ghosh T, Pathania R, Navani NK.

Gene. 2014 Sep 10;548(1):142-8. doi: 10.1016/j.gene.2014.07.003. Epub 2014 Jul 5.

PMID:
24999585
27.

Anesthesia for bronchoscopy.

José RJ, Shaefi S, Navani N.

Curr Opin Anaesthesiol. 2014 Aug;27(4):453-7. doi: 10.1097/ACO.0000000000000087. Review.

PMID:
24785119
28.

Identification of novel regulatory small RNAs in Acinetobacter baumannii.

Sharma R, Arya S, Patil SD, Sharma A, Jain PK, Navani NK, Pathania R.

PLoS One. 2014 Apr 4;9(4):e93833. doi: 10.1371/journal.pone.0093833. eCollection 2014.

29.

Cell migration leads to spatially distinct but clonally related airway cancer precursors.

Pipinikas CP, Kiropoulos TS, Teixeira VH, Brown JM, Varanou A, Falzon M, Capitanio A, Bottoms SE, Carroll B, Navani N, McCaughan F, George JP, Giangreco A, Wright NA, McDonald SA, Graham TA, Janes SM.

Thorax. 2014 Jun;69(6):548-57. doi: 10.1136/thoraxjnl-2013-204198. Epub 2014 Feb 18.

30.

Synthesis, characterization and bactericidal activity of silica/silver core-shell nanoparticles.

Devi P, Patil SD, Jeevanandam P, Navani NK, Singla ML.

J Mater Sci Mater Med. 2014 May;25(5):1267-73. doi: 10.1007/s10856-014-5165-9. Epub 2014 Feb 11.

PMID:
24515862
31.

High prevalence of malignancy in HIV-positive patients with mediastinal lymphadenopathy: a study in the era of antiretroviral therapy.

Alçada J, Taylor MN, Shaw PJ, Janes SM, Navani N, Miller RF.

Respirology. 2014 Apr;19(3):339-45. doi: 10.1111/resp.12241. Epub 2014 Jan 29.

32.

Synergistic action of cinnamaldehyde with silver nanoparticles against spore-forming bacteria: a case for judicious use of silver nanoparticles for antibacterial applications.

Ghosh IN, Patil SD, Sharma TK, Srivastava SK, Pathania R, Navani NK.

Int J Nanomedicine. 2013;8:4721-31. doi: 10.2147/IJN.S49649. Epub 2013 Dec 10.

33.

Impact of EBUS-TBNA on modalities for tissue acquisition in patients with lung cancer.

José RJ, Shaw P, Taylor M, Lawrence DR, George PJ, Janes SM, Navani N.

QJM. 2014 Mar;107(3):201-6. doi: 10.1093/qjmed/hct233. Epub 2013 Nov 19.

34.

Endobronchial ultrasound-guided transbronchial needle aspiration for lymphoma: the final frontier.

Navani N, Janes SM.

Am J Respir Crit Care Med. 2013 Nov 15;188(10):1183-5. doi: 10.1164/rccm.201309-1701ED. No abstract available.

35.

EBUS-TBNA with ROSE-tinted spectacles?

Hardavella G, Navani N.

Respiration. 2013;86(5):439. doi: 10.1159/000355085. Epub 2013 Oct 31. No abstract available.

36.

Reply: Optimum performance of endobronchial ultrasound-guided transbronchial needle aspiration.

Navani N, Janes SM.

Am J Respir Crit Care Med. 2013 Nov 1;188(9):1164-5. doi: 10.1164/rccm.201305-0987LE. No abstract available.

PMID:
24180446
37.

British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE.

Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, Mandal S, Martin J, Mills J, Navani N, Rahman NM, Wrightson JM, Munavvar M; British Thoracic Society Bronchoscopy Guideline Group.

Thorax. 2013 Aug;68 Suppl 1:i1-i44. doi: 10.1136/thoraxjnl-2013-203618. No abstract available.

PMID:
23860341
38.

Summary of the British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults.

Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, Mandal S, Martin J, Mills J, Navani N, Rahman NM, Wrightson JM, Munavvar M; British Thoracic Society Bronchoscopy Guideline Group.

Thorax. 2013 Aug;68(8):786-7. doi: 10.1136/thoraxjnl-2013-203629. Review.

PMID:
23842821
39.

Sedation for flexible bronchoscopy: current and emerging evidence.

José RJ, Shaefi S, Navani N.

Eur Respir Rev. 2013 Jun 1;22(128):106-16. doi: 10.1183/09059180.00006412. Review.

40.

Reply: lung cancer diagnosis and staging centers.

Navani N, Janes SM.

Am J Respir Crit Care Med. 2013 Feb 15;187(4):451. No abstract available.

41.

Reply: endobronchial ultrasound–guided transbronchial needle aspiration versus cervical mediastinoscopy: case selection is needed to maintain clinical as well as cost benefits.

Navani N, Janes SM; REMEDY Trial Management Group.

Am J Respir Crit Care Med. 2013 Feb 15;187(4):449. No abstract available.

PMID:
23536935
42.

Downregulation of yidC in Escherichia coli by antisense RNA expression results in sensitization to antibacterial essential oils eugenol and carvacrol.

Patil SD, Sharma R, Srivastava S, Navani NK, Pathania R.

PLoS One. 2013;8(3):e57370. doi: 10.1371/journal.pone.0057370. Epub 2013 Mar 4.

43.

Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer?

Langley RE, Stephens RJ, Nankivell M, Pugh C, Moore B, Navani N, Wilson P, Faivre-Finn C, Barton R, Parmar MK, Mulvenna PM; QUARTZ Investigators.

Clin Oncol (R Coll Radiol). 2013 Mar;25(3):e23-30. doi: 10.1016/j.clon.2012.11.002. Epub 2012 Dec 2.

PMID:
23211715
44.

Endobronchial ultrasound-guided transbronchial needle aspiration prevents mediastinoscopies in the diagnosis of isolated mediastinal lymphadenopathy: a prospective trial.

Navani N, Lawrence DR, Kolvekar S, Hayward M, McAsey D, Kocjan G, Falzon M, Capitanio A, Shaw P, Morris S, Omar RZ, Janes SM; REMEDY Trial Investigators.

Am J Respir Crit Care Med. 2012 Aug 1;186(3):255-60. Epub 2012 May 31.

45.

Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients.

Navani N, Brown JM, Nankivell M, Woolhouse I, Harrison RN, Jeebun V, Munavvar M, Ng BJ, Rassl DM, Falzon M, Kocjan G, Rintoul RC, Nicholson AG, Janes SM.

Am J Respir Crit Care Med. 2012 Jun 15;185(12):1316-22. doi: 10.1164/rccm.201202-0294OC. Epub 2012 Apr 13.

46.

Screening for lung cancer: is this the way forward?

Spiro SG, Navani N.

Respirology. 2012 Feb;17(2):237-46. doi: 10.1111/j.1440-1843.2011.02114.x. Review.

PMID:
22142440
47.

Pulmonary mass in a 19-year-old male. Inflammatory myofibroblastic tumour.

Smith LJ, Lawrence DR, Kayani I, Capitanio A, Falzon M, Janes SM, Navani N.

Thorax. 2012 May;67(5):468-70. doi: 10.1136/thoraxjnl-2011-200732. Epub 2011 Nov 21. No abstract available.

48.

Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with tuberculous intrathoracic lymphadenopathy: a multicentre study.

Navani N, Molyneaux PL, Breen RA, Connell DW, Jepson A, Nankivell M, Brown JM, Morris-Jones S, Ng B, Wickremasinghe M, Lalvani A, Rintoul RC, Santis G, Kon OM, Janes SM.

Thorax. 2011 Oct;66(10):889-93. doi: 10.1136/thoraxjnl-2011-200063. Epub 2011 Aug 3.

49.

Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of intrathoracic lymphadenopathy in patients with extrathoracic malignancy: a multicenter study.

Navani N, Nankivell M, Woolhouse I, Harrison RN, Munavvar M, Oltmanns U, Falzon M, Kocjan G, Rintoul RC, Janes SM.

J Thorac Oncol. 2011 Sep;6(9):1505-9. doi: 10.1097/JTO.0b013e318223c3fe.

50.

Combination of endobronchial ultrasound-guided transbronchial needle aspiration with standard bronchoscopic techniques for the diagnosis of stage I and stage II pulmonary sarcoidosis.

Navani N, Booth HL, Kocjan G, Falzon M, Capitanio A, Brown JM, Porter JC, Janes SM.

Respirology. 2011 Apr;16(3):467-72. doi: 10.1111/j.1440-1843.2011.01933.x.

Supplemental Content

Loading ...
Support Center